Area of research
Genetics · Hematology
Research interest
Research interests include Medicine, Internal medicine, Disease, Acute chest syndrome, Anemia, and Population.
<scp>GLP</scp>‐1 agonists and <scp>SGLT</scp>‐2 inhibitors in adults with sickle cell disease
Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response
Community‐level socioeconomic distress is associated with nutritional status in adults with sickle cell anemia
Alkaline Phosphatase As a Marker for Acute Complications in Sickle Cell Disease
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
COVID‐19 infection in patients with sickle cell disease
Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso‐occlusive Pain Crises in Patients with Sickle Cell Disease
Systematic Review of Voxelotor: A First‐in‐Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease
Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six‐year population‐based cohort analysis
The morbidity and mortality of end stage renal disease in sickle cell disease
“Maximum tolerated dose” vs “fixed low‐dose” hydroxyurea for treatment of adults with sickle cell anemia
HMOX1 and acute kidney injury in sickle cell anemia
Risk factors for vitamin D deficiency in sickle cell disease
Hemolysis and hemolysis‐related complications in females vs. males with sickle cell disease
Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6‐year population‐based cohort study
Characterization of opioid use in sickle cell disease
Use of anti-inflammatory analgesics in sickle-cell disease
Erythropoiesis‐stimulating agents in sickle cell anaemia
<i>APOL1</i> , α-thalassemia, and <i>BCL11A</i> variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia
Patterns of opioid use in sickle cell disease
Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center
Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease
Platelets decline during <scp>V</scp>aso‐occlusive crisis as a predictor of acute chest syndrome in sickle cell disease
On Limitations of Designing Usable Leakage-Resilient Password Systems: Attacks, Principles and Usability
Institutional Knowledge (InK) - Institutional Knowledge at Singapore Management University (Singapore Management University) 2012cited by 57position: middle
Targeting Protein Tyrosine Kinase 6 Enhances Apoptosis of Colon Cancer Cells following DNA Damage